Abstract
To selectively express cell-type specific transcripts during development, it is critical to maintain genes required for other lineages in a silent state. Here we show in the Drosophila male germ line stem cell lineage that a spermatocyte specific zinc finger protein, Kumgang (Kmg), working with the chromatin remodeler, dMi-2, prevents transcription of genes normally expressed only in somatic lineages. By blocking transcription from normally cryptic promoters, Kmg restricts activation by Aly, a component of the testis-meiotic arrest complex (tMAC), to transcripts for male germ cell differentiation. Our results suggest that as new regions of the genome become open for transcription during terminal differentiation, blocking the action of a promiscuous activator on cryptic promoters is a critical mechanism for specifying precise gene activation.
Highly specialized cell types such as red blood cells, intestinal epithelium, and spermatozoa are produced throughout life from adult stem cells. In such lineages, mitotically dividing precursors commonly stop proliferation and initiate a novel, cell-type specific transcription program that sets up terminal differentiation of the specialized cell type. In the Drosophila male germ line, stem cells at the apical tip of the testis self-renew and produce daughter cells that each undergo four rounds of spermatogonial mitotic transit amplifying (TA) divisions, after which the germ cells execute a final round of DNA synthesis (pre-meiotic S phase) and initiate terminal differentiation as spermatocytes (Fig. 1A) (1). Transition to the spermatocyte state is accompanied by transcriptional activation of >1,500 genes, many of which are expressed only in male germ cells (2). Expression of two thirds of these depends both on a testis-specific version of the MMB/dREAM complex termed the testis meiotic arrest complex (tMAC) and on testis-specific paralogs of TATA binding protein associated factors (tTAFs) (3–5). Although this is one of the most dramatic changes in gene expression in Drosophila (6), it is not yet understood how the testis-specific transcripts are selectively activated during the three day spermatocyte period.
Identification of an early differentiation gene, kumgang
To identify the first transcripts upregulated at onset of spermatocyte differentiation (fig. S1A, arrow), we genetically manipulated germ cells to synchronously differentiate from spermatogonia to spermatocytes in vivo utilizing bam−/− testes, which contain large numbers of overproliferating spermatogonia (fig. S1B and C) (7–8). Brief restoration of Bam expression under heat shock control in hs-bam; bam−/− flies induced synchronous differentiation of bam−/− spermatogonia, resulting in completion of a final mitosis, pre-meiotic DNA synthesis and onset of spermatocyte differentiation by 24 hours after Bam expression, eventually leading to production of functional sperm (Fig. 1B and fig. S1D-O and S2; supplementary text). Comparison of transcripts expressed before vs. 24 hours after heat shock of hs-bam; bam−/− testes by microarray identified 27 early transcripts significantly upregulated more than 2-fold in testes from hs-bam; bam−/− (Fig. 1C, red) but not from bam−/− flies subjected to the same heat shock regime (fig. S3A). Among these was the early spermatocyte marker RNA binding protein 4 (Rbp4) (Fig. 1C and table S1) (9). Notably at this early time point, the transcript for CG5204, now named kumgang (kmg) based on the Korean name of mythological guardians at the gate of Buddhist temples, had the highest fold increase among all 754 Drosophila predicted transcription factors (Fig. 1C and table S1) (10).
Kumgang (CG5204) encodes a 747 amino acid protein with six canonical C2H2-type zinc finger domains (fig. S4A) expressed in testes but not in ovary or carcass (fig. S3B). Kmg protein was expressed independently from the tMAC component Always early (Aly) or the tTAF Spermatocyte Arrest (Sa) (fig. S3C), and both kmg mRNA and protein were upregulated prior to Topi, another component of tMAC (fig. S3D and E) (3, 11). Immunofluorescence staining of wild-type testes revealed Kmg protein expressed specifically in differentiating spermatocytes (Fig. 1D and fig. S3F-H), where it was nuclear and enriched on the partially condensed bivalent chromosomes (Fig. 1E-E″). Consistent with dramatic upregulation of kmg mRNA after the switch from spermatogonia to spermatocyte (Fig. 1C and fig. S3D), expression of Kmg was first detected by immunofluorescence staining after completion of pre-meiotic S phase marked by downregulation of Bam (fig. S3I-I″) (12), coinciding with expression of Rbp4 protein (fig. S3J-J″), and before expression of the tTAF, Sa (fig. S3K- K″).
Kmg prevents misexpression of genes normally expressed in somatic cells
Function of Kmg in spermatocytes was required for male germ cell differentiation. Reducing function of Kmg in spermatocytes, either by cell-type specific RNAi knock down (KD) (Fig. 2A, B and fig. S4A, B) or in flies trans-heterozygous for a CRISPR-induced kmg frameshift mutant and a chromosomal deficiency (kmgΔ7/Df) (fig. S3A, C, E and F), resulted in accumulation of mature primary spermatocytes arrested just prior to the G2/M transition for meiosis I and lack of spermatid differentiation. A 4.3 kb genomic rescue transgene containing the 2.3kb kmg open reading frame (fig. S4A) fully rescued the differentiation defects and sterility of kmgΔ7/Df flies (fig. S4D), confirming that the meiotic arrest phenotype was due to loss of function of Kmg. In both kmg KD and kmgΔ7/Df, Kmg protein levels were less than 5% of wild-type (fig. S4G; supplementary text). kmgΔ7/Df mutant animals were adult viable and female fertile but male sterile, consistent with the testis-specific expression.
Function of Kmg was required in germ cells for repression of over 400 genes not normally expressed in wild-type spermatocytes. Although the differentiation defects caused by loss of function of kmg appeared similar to the meiotic arrest phenotype of testis-specific tMAC component mutants by phase contrast microscopy, analysis of gene expression in kmg KD testes showed that many Aly (tMAC) dependent spermatid differentiation genes were expressed, although some at lower level than in wild-type. Among the 652 genes with 256-fold lower expression in aly−/− mutant compared to wild-type testes (Fig. 2D, green dots and table S2), only 4 showed 256-fold lower expression in kmg KD compared to sibling control (no Gal4 driver) testes (Fig. 2C, green dots). In contrast, transcripts from over 500 genes were strongly upregulated in kmg KD testes with almost no detectable expression in testes from sibling control males (Fig. 2C, red dots). Hierarchical clustering identified 440 genes specifically upregulated in kmg KD testes (fig. S5A, red line, and table S3) compared to testes from wild-type, bam−/−, aly−/− or sa−/− mutant flies. These 440 genes were significantly associated with Gene Ontology terms such as ‘substrate specific channel activity’ or ‘detection of visible light’ that appeared more applicable to non-germ cell types, such as neurons (fig. S5B). Analysis of published transcript expression data for a variety of Drosophila tissues (6) revealed that the 440 were normally not expressed or extremely low in wild-type adult testes, but many were expressed in specific differentiated somatic tissues such as eye, brain or gut (fig. S5C). Confirming misexpression of neuronal genes at the protein level, immunofluorescence staining revealed that the neuronal transcription factor Prospero (Pros) (13), normally not detected in male germ cells, was expressed in clones of spermatocytes homozygous mutant for kmg induced by Flp-FRT mediated mitotic recombination (Fig. 2E-E‴). The misexpression of Pros was cell autonomous, occurring only in mutant germ cells. Notably, mid stage to mature spermatocytes homozygous mutant for kmg misexpressed Pros (Fig. 2E′-E‴, arrow), but mutant early spermatocytes did not (Fig. 2E′-E‴, arrowhead), indicating that the abnormal upregulation of Pros occurred only after spermatocytes had reached a specific stage in their differentiation program.
Kmg functions with dMi-2 to repress misexpression of normally somatic transcripts
A small-scale cell-type specific RNAi screen of chromatin regulators revealed that knock down of dMi-2 in late TA cells and spermatocytes resulted in meiotic arrest, similar to loss of function of kmg (Fig. 3A and table S4). Immunofluorescence analysis of testes from a protein trap line in which an endogenous allele of dMi-2 was tagged by GFP revealed that dMi-2-GFP, like the untagged endogenous protein (fig. S6A-A‴), was expressed and nuclear in progenitor cells and spermatocytes, as well as in somatic hub and cyst cells (fig. S6B′ and B″). Notably, dMi-2-GFP co-localized to chromatin with Kmg in spermatocytes (fig. S6B-B′ and B‴–C‴) and the level of dMi-2 protein appeared lower and less concentrated on chromatin in nuclei of kmg−/− spermatocytes than in neighboring kmg+/+ or +/− spermatocytes, suggesting that Kmg may at least partially help recruit dMi-2 to chromatin in spermatocytes (Fig. 3B-B‴ and fig. S6D-F). Furthermore, in testis extracts Kmg co-immunoprecipitated with dMi-2 and vice versa, suggesting that Kmg and dMi-2 form a protein complex in spermatocytes (Fig. 3C). Comparison of microarray data revealed that most of the 440 transcripts upregulated in testes upon loss of function of kmg were also abnormally upregulated in dMi-2 KD testes (Fig. 3D), suggesting that Kmg and dMi-2 may function together to repress expression of the same set of normally somatic transcripts in spermatocytes.
Chromatin immunoprecipitation followed by sequencing (ChIP-Seq) revealed that Kmg protein localized along the bodies of genes actively transcribed in the testis. ChIP-Seq with anti-Kmg identified 798 genomic regions strongly enriched by immunoprecipitation of Kmg (peaks, q value < 10−10) from wild-type but not from kmg KD testes. 698 of the 798 robust Kmg ChIP-Seq peaks overlapped with exonic regions of 680 different genes actively transcribed in testes (Fig. 3E and fig. S7A, C, E, G, I and table S5). The enrichment was often strongest just downstream of the transcription start site (TSS), but with substantial enrichment along the gene body as well (Fig. 3E and fig. S7A, C, E, G).
ChIP-Seq with anti-dMi-2 also showed enrichment along the gene bodies of the same 680 genes bound by Kmg, with a similar bias just downstream of the TSS (Fig. 3E and fig. S7B, D, F, H). The dMi-2 ChIP signal along these genes was partially reduced in kmg KD testes, suggesting that Kmg may recruit dMi-2 to the bodies of genes actively transcribed in the testis (Fig. 3E and fig. S7B, D, F, H).
RNA-Seq analysis revealed that the 680 genes bound by Kmg were strongly expressed in testes (Fig. 3E and fig. S7I-K) and most strongly enriched in the GO term categories ‘spermatogenesis’ and ‘male gamete generation’ (fig. S8A). One third of the genes bound by Kmg were robustly activated as spermatogonia differentiate into spermatocytes, and were much more highly expressed in the testes than in other tissues (fig. S8B, red rectangle). The median levels of transcript expression of most of the 680 Kmg bound genes did not change significantly upon loss of Kmg (fig. S7J and K).
Genes that are normally transcribed in somatic cells that became upregulated upon loss of Kmg function in spermatocytes for the most part did not appear to be bound by Kmg. Only 3 of the 440 genes upregulated in kmg KD overlapped with the 680 genes with robust Kmg peaks, suggesting that Kmg may prevent misexpression of normally somatic transcripts either indirectly or by acting at a distance.
Kmg and dMi-2 prevent misexpression from cryptic promoters
Inspection of RNA-Seq reads from kmg and dMi-2 KD testes mapped onto the genome showed that about 80% of the transcripts detected as misexpressed in knock down compared to wild-type testes by microarray analysis did not initiate from the promoters used in the somatic tissues in which the genes are normally expressed (Fig. 4A and C, arrows). Metagene analysis (Fig. 4E), as well as visualization of RNA expression centered on the TSSs annotated in the Ensembl database (fig. S9A) showed that most of the 143 genes normally expressed in wild-type heads but not in wild-type testes were misexpressed in kmg or dMi-2 KD testes from a start site different from the annotated TSS utilized in heads. Transcript assembly from our RNA-Seq data using Cufflinks for the 143 genes also showed that the transcripts misexpressed in kmg or dMi-2 KD testes most often initiate from a different TSSs than the transcripts from the same gene assembled from wild-type heads (fig. S9B-D; supplementary text).
Of the 440 genes scored as de-repressed in kmg KD testes based on microarray, 346 could be assigned with TSSs in kmg KD testes based on visual inspection of our RNA-Seq data mapped onto the genome browser (table S6; supplementary text). Of these, only 67 produced transcripts in kmg KD testes that started within 100bp of the TSS annotated in the Ensembl database based on the tissue(s) in which the gene was normally expressed. In contrast, for rest of the 346 genes, the transcripts expressed in kmg KD testes started from either a TSS upstream (131/346) or downstream (148/346) of the annotated TSSs. 262 of the 346 genes were misexpressed starting from nearly identical positions in dMi-2 KD as in kmg KD testes (table S6), suggesting that Kmg and dMi-2 function together to prevent misexpression from cryptic promoters.
Kmg prevents promiscuous activity of Aly
Many of the ectopic promoters from which the misexpressed transcripts originated appeared to be bound by Aly, a component of tMAC, in kmg KD testes (Fig. 4B, D arrowheads and Fig. 4F, G). ChIP for Aly was performed using anti-HA on testis extracts from flies bearing an Aly-HA genomic transgene able to fully rescue the aly−/− phenotype (fig. S10; see methods). 181 of 346 genes with new TSSs assigned by visual inspection had a region of significant enrichment by ChIP for Aly with its peak summit located within 100bp of the cryptic promoter (Fig 4F and G; supplementary text). Motif analysis by MEME revealed that these regions were enriched for the DNA sequence motif (AGYWGGC) (Fig. 4H and fig. S11). This motif was not significantly enriched in the set of 165 cryptic promoters at which Aly was not detected in kmg KD testes (fig. S11B). Enrichment of Aly at the cryptic promoters was much stronger in kmg KD compared to wild-type testes (Fig. 4B, D and G), suggesting that in the absence of Kmg, Aly may bind to and activate misexpression from cryptic promoters.
Genetic tests revealed that the misexpression of somatic transcripts in kmg KD spermatocytes indeed required function of Aly. The neuronal transcription factor Pros, abnormally upregulated in kmg KD or mutant spermatocytes (Fig. 2E-E‴), was no longer misexpressed if the kmg KD spermatocytes were also mutant for aly (Fig. 5A, B and fig. S12A-F), even though germ cells in kmg KD; aly−/− testes appear to reach the differentiation stage at which Pros turned on in the kmg KD germ cells (fig. S13; supplementary text). Assessment by qRT-PCR revealed that misexpression of 5/5 transcripts in kmg KD testes also required function of Aly (fig. S12G). Global transcriptome analysis of kmg KD vs. kmg KD; aly−/− testes by microarray showed that the majority of the 440 genes de-repressed due to loss of function of kmg in spermatocytes were no longer abnormally upregulated in kmg KD; aly−/− testes (Fig. 5C). Even genes without noticeable binding of Aly at their cryptic promoters were suppressed in kmg KD; aly−/−, suggesting Aly may regulate this group of genes indirectly.
Together our ChIP and RNA-Seq data show that Kmg and dMi-2 bind actively transcribed genes (Fig. 3E and fig. S7) (14), but are required to block expression of aberrant transcripts from other genes normally silent in testes. The mammalian ortholog of dMi-2, CHD4 (Mi-2β) has been shown to bind active genes in mouse embryonic stem cells (15) or T lymphocyte precursors (16), but also plays a role in ensuring lineage specific gene expression in other contexts (17–18). We cannot rule out that Kmg and dMi-2 might also act directly at the cryptic promoter sites but that our ChIP conditions did not capture their transient or dynamic binding, as several chromatin remodelers or transcription factors such as the thyroid hormone receptor have been difficult to detect by ChIP (19–20). Kmg and dMi-2 may repress misexpression from cryptic promoters indirectly by activating as yet unidentified repressor proteins. However, it is also possible that Kmg and dMi-2 act at a distance by modulating chromatin structure or confining transcriptional initiation or elongation licensing machinery to normally active genes.
Indeed, changes in the genomic localization of Aly protein in wild-type vs. kmg KD testes raised the possibility that Kmg may in part prevent misexpression from cryptic promoters by concentrating Aly at active genes. Of the 1,903 Aly peaks identified by ChIP from wild-type testes, the 248 Aly peaks that overlapped with strong Kmg peaks showed an overall reduction in enrichment by ChIP of Aly from kmg KD testes compared to wild-type (Fig. 6A–C, Case #1 and fig. S14A and B). In contrast, the Aly peaks at cryptic promoters were more robust in kmg KD testes than in wild-type (Fig. 4G). In general over the genome, 4,129 new Aly peaks were identified by ChIP from kmg KD testes that were absent or did not pass the statistical cutoff in wild-type testes (Fig. 6A–C, Case #2 and fig. S14A). More than 30% of the genomic regions with new Aly peaks in kmg KD showed elevated levels of RNA expression starting at or near the Aly peak in kmg KD but not in wild-type testes (Fig. 6D and fig. S14C), suggesting that misexpression of transcripts from normally silent promoters in kmg KD testes is more widespread than initially assessed by microarray. Together, these findings raise the possibility that Kmg may prevent misexpression of aberrant transcript by concentrating Aly to active target genes in wild-type testes, so preventing binding and action of Aly at cryptic promoter sites.
Our results suggest that selective gene activation is not always mediated by a precise transcriptional activator, but can instead be directed by combination of a promiscuous activator and a gene-selective licensing mechanism (fig. S15A). Cryptic promoters may become accessible as chromatin organization is reshaped to allow expression of terminal differentiation transcripts that were tightly repressed in the progenitor state. We posit that this chromatin organization makes a number of sites accessible for transcription dependent on the testis-specific tMAC complex component Aly. In this context, activity of Kmg and dMi-2 is required to prevent productive transcript formation from unwanted initiation sites, potentially by confining Aly to genes actively transcribed in the testis and limiting the amount of Aly protein acting at cryptic promoters.
The initiation of novel transcripts from cryptic promoters is reminiscent of loss of function of Ikaros, a critical regulator of T and B cell differentiation (21) and a tumor suppressor in the lymphocyte lineage (22–23). Like Kmg, Ikaros is a multiple zinc finger protein associated with Mi-2β, which binds to active genes in T and B cell precursors (16, 24). Notably, in T-cell lineage acute lymphoblastic leukemia (T-ALL) associated with loss of function of Ikaros, cryptic intragenic promoters were activated leading to expression of ligand independent Notch1 protein, contributing to leukemogenesis (25). Thus, in addition to being detrimental for proper differentiation, firing of abnormal transcripts from normally cryptic promoters due to defects in chromatin regulators may contribute to tumorigenesis through generation of novel oncogenic proteins.
Supplementary Material
Acknowledgments
We thank L. Di Stefano, H. White-Cooper, X. Chen, F. Port, S. Bullock, A. Kuo, G. Crabtree, S. Park, S. Kim, J. Wysocka and G. Ramaswami for advice and generously sharing data and reagents, members of the Fuller lab. for discussions and critical reading of the manuscript, the Stanford CSIF for fluorescence microscopy (NCRR grants S10RR017959-01 and 1S10OD010580) and the SFGF for high-throughput sequencing. Genomic data are available under NCBI GEO (GSE89506). J. K. was supported by the Anne T. and Robert M. Bass Stanford Graduate Fellowship and the Bruce and Elizabeth Dunlevie Bio-X Stanford Interdisciplinary Graduate Fellowship. Research support: DFG TRR81 to A.B. and S.A.; Kempkes Stiftung to S.A; NIH 5R01GM061986 and the Reed-Hodgson Professorship in Human Biology to M.T.F.
Footnotes
Materials and Methods
Supplementary figures S1–S15 and legends
Captions for table S1–3 and S5–8
References (28–54)
References and Notes
- 1.Fuller MT. Cold Spring Harbor Laboratory Press. 1993;1:71. [Google Scholar]
- 2.White-Cooper H, Caporilli S. Advances in experimental medicine and biology. 2013;786:47. doi: 10.1007/978-94-007-6621-1_4. [DOI] [PubMed] [Google Scholar]
- 3.Beall EL, et al. Genes & development. 2007 Apr 15;21:904. doi: 10.1101/gad.1516607. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Hiller MA, Lin TY, Wood C, Fuller MT. Genes & development. 2001 Apr 15;15:1021. doi: 10.1101/gad.869101. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.White-Cooper H, Leroy D, MacQueen A, Fuller MT. Development (Cambridge, England) 2000 Dec;127:5463. doi: 10.1242/dev.127.24.5463. [DOI] [PubMed] [Google Scholar]
- 6.Chintapalli VR, Wang J, Dow JA. Nature genetics. 2007 Jun;39:715. doi: 10.1038/ng2049. [DOI] [PubMed] [Google Scholar]
- 7.Gonczy P, Matunis E, DiNardo S. Development (Cambridge, England) 1997 Nov;124:4361. doi: 10.1242/dev.124.21.4361. [DOI] [PubMed] [Google Scholar]
- 8.McKearin DM, Spradling AC. Genes & development. 1990 Dec;4:2242. doi: 10.1101/gad.4.12b.2242. [DOI] [PubMed] [Google Scholar]
- 9.Baker CC, Gim BS, Fuller MT. Development (Cambridge, England) 2015 Oct 1;142:3394. doi: 10.1242/dev.122341. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Adryan B, Teichmann SA. Bioinformatics (Oxford, England) 2006 Jun 15;22:1532. doi: 10.1093/bioinformatics/btl143. [DOI] [PubMed] [Google Scholar]
- 11.Perezgasga L, et al. Development (Cambridge, England) 2004 Apr;131:1691. doi: 10.1242/dev.01032. [DOI] [PubMed] [Google Scholar]
- 12.Insco ML, Leon A, Tam CH, McKearin DM, Fuller MT. Proceedings of the National Academy of Sciences of the United States of America. 2009 Dec 29;106:22311. doi: 10.1073/pnas.0912454106. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Doe CQ, Chu-LaGraff Q, Wright DM, Scott MP. Cell. 1991 May 3;65:451. doi: 10.1016/0092-8674(91)90463-9. [DOI] [PubMed] [Google Scholar]
- 14.Mathieu EL, et al. Nucleic Acids Res. 2012 Jun;40:4879. doi: 10.1093/nar/gks178. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.de Dieuleveult M, et al. Nature. 2016 Feb 4;530:113. doi: 10.1038/nature16505. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Zhang J, et al. Nat Immunol. 2012 Jan;13:86. [Google Scholar]
- 17.Gomez-Del Arco P, et al. Cell Metab. 2016 May 10;23:881. doi: 10.1016/j.cmet.2016.04.008. [DOI] [PubMed] [Google Scholar]
- 18.O’Shaughnessy-Kirwan A, Signolet J, Costello I, Gharbi S, Hendrich B. Development (Cambridge, England) 2015 Aug 1;142:2586. doi: 10.1242/dev.125450. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Gelbart ME, Bachman N, Delrow J, Boeke JD, Tsukiyama T. Genes & development. 2005 Apr 15;19:942. doi: 10.1101/gad.1298905. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Grontved L, et al. Nat Commun. 2015;6:7048. doi: 10.1038/ncomms8048. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Georgopoulos K. Nat Rev Immunol. 2002 Mar;2:162. doi: 10.1038/nri747. [DOI] [PubMed] [Google Scholar]
- 22.Mullighan CG, et al. N Engl J Med. 2009 Jan 29;360:470. doi: 10.1056/NEJMoa0808253. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Winandy S, Wu P, Georgopoulos K. Cell. 1995 Oct 20;83:289. doi: 10.1016/0092-8674(95)90170-1. [DOI] [PubMed] [Google Scholar]
- 24.Schwickert TA, et al. Nat Immunol. 2014 Mar;15:283. doi: 10.1038/ni.2828. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Gomez-del Arco P, et al. Immunity. 2010 Nov 24;33:685. doi: 10.1016/j.immuni.2010.11.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Chen X, Lu C, Morillo Prado JR, Eun SH, Fuller MT. Development (Cambridge, England) 2011 Jun;138:2441. doi: 10.1242/dev.056572. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Celniker SE, et al. Nature. 2009 Jun 18;459:927. doi: 10.1038/459927a. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.